Mainstream

Imunon outlines rapid OVATION 3 Phase III trial launch and initiates 15% stock dividend to support shareholder value

Imunon outlines rapid OVATION 3 Phase III trial launch and initiates 15% stock dividend to support shareholder value

Post ContentimnnRead More

You might also be interested in reading Australia, Canada and Colombia were right to pause CBDC plans.

August 5, 2025
In Mainstream